![]() |
| (c) Kyodo News |
Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world. We also manage the Orange County Eye Project in Santa Ana, CA.
Showing posts with label Clinical Trial. Show all posts
Showing posts with label Clinical Trial. Show all posts
Saturday, October 17, 2020
World's first transplant of iPS visual cells for retinal disease
Tuesday, December 18, 2018
Injection Improves Vision in a Form of Childhood Blindness
| (c) NIH |
Monday, October 9, 2017
FDA to soon decide approval for Spark Therapeutics' gene therapy for Leber Congenital Amaurosis
In the next few days, FDA panel will consider whether to advice approval for gene therapy for Leber's Congenital Amaurosis (LCA), which has been extensively tested in clinical trials by Spark Therapeutics.
Tuesday, September 29, 2015
First patient receives potential new treatment for wet age-related macular degeneration (AMD)
A pioneering trial of a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) has commenced at Moorfields Eye Hospital following a successful operation on a patient.
Monday, August 24, 2015
RetroSense Therapeutics Gets Approval for Clinical Trials in Retinitis Pigmentosa
| (c) nature.com |
Wednesday, August 12, 2015
UCI-led team begins first clinical trial of stem cell-based retinitis pigmentosa treatment
Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa. The product of stem cell research at UCI’s Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center, these retinal progenitors are similar to stem cells in terms of potential regenerative properties, but they’re specific to the retina.
Subscribe to:
Posts (Atom)

